9th World Congress on Bioavailability and Bioequivalence

April 16-18, 2018 ∣ Dubai ,UAE

Theme: Unfolding Innovations in Bioequivalence and Bioavailability and Related Science

Conference URL:http://bioavailability-bioequivalence.pharmaceuticalconferences.com/

 

Conference short name: BABE 2018

We are so glad to organize “9th World Congress on Bioavailability and Bioequivalence” (BABE 2018) in UAE on April 16-18, 2018 at Dubai after a similar series of conferences in consecutive years at USA over the last several years which met with great achievement in Business Conferencing. This unique international conference will opportunity to reach the largest assemblage of participants from the Pharmaceutical community to gather and share their insights and convey recent developments in the field of generic drug research and current challenges and possibilities in modelling a new drug and breakthroughs in drug development, Generic drug safety, Novel trends and advanced strategies involving bioavailability bioequivalence research. This is a true forum where ideas and discussion is driven by the participants and interaction with peers and others leads to fruitful outcomes.

 

BABE 2018 is a 3-day event offering the Exhibition, at venue to showcase the new and emerging technologies and have wider sessions involving Keynote presentation, Oral, YRF (student presentation), poster, e-poster presentations. World-renowned speakers and eminent delegates across the globe attending the conference, to share their valuable presentation on the most recent and advanced techniques, developments, and the newest updates are the prominent features of the conference.

 

Target audience:

• CEOs, CROs, Directors, Managers and research associates
• Academic and Industrial Scientists
• Regulatory and Clinical Scientists
• Researchers, Education providers
• Students and Postdoctoral Fellows
• Government Agencies
• Medical Practitioners
• Clinical Pharmacologists
• Clinical Toxicologists
• Molecular and Cellular Pharmacologists

 

Conference Highlights

Bioavailability and Bioequivalence

Bioavailability Studies and Assessment

Bioequivalence Studies and Assessment

Drug Design and development: Challenges

Drug Metabolism

Pharmacology- PK & PD approach

Pharmaceutical Formulations

Clinical Research Vs Clinical Trails

BCS & IVIVC Based Biowaivers

Biosimilars: Recent approaches

Drug Safety: Pharmacovigilance Scope

Contract Research Organizations

Regulatory Requirements and Approaches

Pharmaceutical Industry: Entrepreneur Meet

BA/BE Perspectives for Drug Products

 

contact :

Patrica Jones

Program Manager

BABE 2018

Kemp House,

152 City Road,

London EC1V 2NX,

UK

Direct:(702) 508-5200 Ext:8122

Email:babe@conferenceseries.net